Global Protein Engineering Market

Global Protein Engineering Market Size, Share, Growth Analysis, By Product(Instruments, Reagents), By Technology(Rational Protein Design, Directed Evolution), By Protein Type(Insulin, Monoclonal Antibodies), By End-User(Academic Research Institutes, Contract Research Organizations) - Industry Forecast 2024-2031

Report ID: SQMIG35H2172 | Region: Global | Published Date: March, 2024
Pages: 219 | Tables: 124 | Figures: 77

Global Protein Engineering Market Competitive Landscape

The global protein engineering market is highly competitive in nature, with several key players operating worldwide. These companies are actively involved in research and development activities, strategic partnerships, mergers and acquisitions, and product launches to strengthen their market presence. To enhance their industry footprint, prominent firms are pursuing a variety of essential tactics such as collaborations, mergers, acquisitions, and so on. For example, in 2022, Creative BioMart improved its protein engineering planning and evaluation services to aid researchers in resolving protein engineering challenges.

Top Player’s Company Profiles in Global Protein Engineering Market

  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Agilent Technologies, Inc.
  • Genscript Biotech Corporation
  • Codexis, Inc.
  • Danaher Corporation
  • Bio-Rad Laboratories, Inc.
  • Bruker Corporation
  • PerkinElmer, Inc.
  • Creative Biomart
  • Abcam plc
  • Enzyme by Design Ltd.
  • Twist Bioscience Corporation
  • GenScript Biotech Corporation
  • Cyrus Biotechnology, Inc.
  • Integrated DNA Technologies, Inc. (IDT)
  • New England Biolabs
  • Genentech, Inc.
  • Promega Corporation
  • Sutro Biopharma, Inc.

Global Protein Engineering Market

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

 

The global protein engineering market is highly competitive in nature, with several key players operating worldwide. These companies are actively involved in research and development activities, strategic partnerships, mergers and acquisitions, and product launches to strengthen their market presence. To enhance their industry footprint, prominent firms are pursuing a variety of essential tactics such as collaborations, mergers, acquisitions, and so on. For example, in 2022, Creative BioMart improved its protein engineering planning and evaluation services to aid researchers in resolving protein engineering challenges. 'Thermo Fisher Scientific Inc.', 'Merck KGaA', 'Agilent Technologies, Inc.', 'Genscript Biotech Corporation', 'Codexis, Inc.', 'Danaher Corporation', 'Bio-Rad Laboratories, Inc.', 'Bruker Corporation', 'PerkinElmer, Inc.', 'Creative Biomart', 'Abcam plc', 'Enzyme by Design Ltd.', 'Twist Bioscience Corporation', 'GenScript Biotech Corporation', 'Cyrus Biotechnology, Inc.', 'Integrated DNA Technologies, Inc. (IDT)', 'New England Biolabs', 'Genentech, Inc.', 'Promega Corporation', 'Sutro Biopharma, Inc.'

Protein engineering plays a crucial role in the development of therapeutic proteins, such as antibodies, enzymes, and hormones. The growing prevalence of chronic diseases and the rising demand for targeted and personalized therapies are driving the need for novel and optimized therapeutic proteins.

Increasing Demand for Personalized Medicine: There is a growing demand for personalized medicine, where treatments are tailored to individual patients based on their genetic makeup. Protein engineering enables the development of customized therapeutic proteins and antibodies that can target specific diseases and improve patient outcomes.

North America will dominate the global industry in 2022, accounting for over 40.75% of total sales. The region is predicted to maintain its leadership over the forecast period. A growing number of collaborations promoted by leading market participants to increase their R&D skills are expected to be responsible for this region's larger share. The major goal of the partnership was to create a unique interleukin-2 (IL-2) agonist designed to specifically boost regulatory T cell (Treg) proliferation for the treatment of autoimmune diseases.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Global Protein Engineering Market

Report ID: SQMIG35H2045 | Region: Global | Published Date: March, 2024 | Pages: 157 | Tables: 121 | Figures: 78

Global Targeted Protein Degradation Market
Buy Now GET FREE SAMPLE
Global Protein Engineering Market

Report ID: SQMIG35H2055 | Region: Global | Published Date: March, 2024 | Pages: 219 | Tables: 64 | Figures: 76

Global Microbubbles/Ultrasound Contrast Agents Market
Buy Now GET FREE SAMPLE
Global Protein Engineering Market

Report ID: UCMIG35H2236 | Region: Global | Published Date: March, 2024 | Pages: 165 | Tables: Figures:

Immunoassay Interference Blocker Market
Buy Now GET FREE SAMPLE
Global Protein Engineering Market

Report ID: UCMIG35H2152 | Region: Global | Published Date: March, 2024 | Pages: 165 | Tables: Figures:

Microbial Fermentation Technology Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Protein Engineering Market

Product ID: SQMIG35H2172

$5,300
BUY NOW GET FREE SAMPLE